Li-Li Wang

Li-Li Wang

Auto-generated profile, based on publicly available information

Li-Li Wang

Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College , Hangzhou, Zhejiang 310014

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2025 in ACS Polymers Au
Verified
Journal Article
Open access
QJQiang Jin
Qiang Jin
MJMiao-Yun Jiang
Miao-Yun Jiang
LWLi-Li Wang
Li-Li Wang
SLShi-Qi Lin
Shi-Qi Lin
TLTing Li
Ting Li
YSYi Sun
Yi Sun
Chronic inflammation is a hallmark of diabetic wounds, severely disrupting the physiological healing cascade. Modulating this inflammatory microenvironment while ensuring biocompatibility remains a major challenge in regenerative medicine. Herein, we report the development of a multifunctional dual-network injectable hydrogel, incorporating glycyrrhizic acid (GA) and acellular fat extracts (FE), designed to enhance diabetic wound repair. The hydrogel comprises two interpenetrating networks: A reversible, dynamic network formed via Zn2+-coordinated GA confers excellent injectability and conformability, allowing tight adherence to irregular wound topographies. A secondary, physically cross-linked network is introduced by ultraviolet (UV)-induced polymerization of methacrylated hyaluronic acid (HAMA), which significantly reinforces mechanical strength and structural stability. GA exhibits inherent immunomodulatory activity, promoting macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype, thereby attenuating local inflammation. Concurrently, FE provides a rich reservoir of pro-angiogenic and regenerative bioactive factors that synergistically promote neovascularization and tissue remodeling. In vitro and in vivo evaluations confirmed that this composite hydrogel accelerates wound closure, reduces inflammatory cytokine expression, enhances angiogenesis, and promotes granulation tissue formation. Collectively, this injectable, immunomodulatory, and pro-regenerative hydrogel platform offers a promising therapeutic strategy for the effective management of recalcitrant diabetic wounds.

22 January 2026 in Regenerative Biomaterials
Verified
Journal Article
Open access
LWLili Wang
Lili Wang
XLXiaoqi Li
Xiaoqi Li
XZXinyu Zhang
Xinyu Zhang
QCQingfei Chu
Qingfei Chu
LYLinjie Ye
Linjie Ye
TLTing li
Ting li
Chronic diabetic wounds remain a major clinical challenge owing to impaired angiogenesis, persistent inflammation and cellular dysfunction. In this study, we developed a bioadhesive composite hydrogel scaffold (gelatin methacryloyl/alginate methacrylate [GA]) fabricated using digital light processing three-dimensional (3D) bioprinting, in which human adipose-derived mesenchymal stem cells (ADSCs) or their conditioned medium (CM) was incorporated to generate 3D skin constructs, and compared the paracrine effects on skin regeneration. We characterized the microstructures of GA-ADSC and GA-CM scaffolds; profiled CM proteins and systematically compared the effects of GA-ADSCs and GA-CM on fibroblast proliferation, migration, angiogenesis and macrophage polarization in vitro. Their therapeutic efficacy was further evaluated in diabetic mouse wound models, including analyses of collagen deposition, angiogenesis and fibrosis markers. Furthermore, proteomic analysis was performed to understand the underlying mechanisms. In vitro, both GA-ADSCs and GA-CM promoted fibroblast proliferation, migration, angiogenesis and macrophage M2 polarization. Moreover, they accelerated wound closure in diabetic mice by enhancing collagen deposition and neovascularization (CD31) and suppressing α-smooth muscle actin and transforming growth factor-β1 expression. Notably, GA-ADSCs showed prolonged cell viability and exhibited stronger immunomodulatory and antifibrotic effects than GA-CM. Proteomic analysis revealed distinct mechanistic differences: GA-ADSCs markedly activated Toll-like receptor signaling, necroptosis and extracellular matrix remodeling pathways, suggesting their key roles in immune regulation and metabolic reprogramming. In contrast, GA-CM primarily activated the Hippo signaling pathway, consistent with its role in growth factor-mediated tissue repair. Furthermore, we compared the differentially regulated proteins between ADSCs and CM in diabetic wounds and showed that ADSCs significantly modulated RGL2, RSPH9 and CRTC3, which are associated with enhanced cellular function and energy metabolism. These findings provide mechanistic insights into ADSC- and CM-mediated effects and support the development of bioinspired stem cell-based therapeutic strategies for chronic diabetic wound repair.